Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
7
×
boston blog main
boston top stories
life sciences
national blog main
biotech
national top stories
new york blog main
new york top stories
san francisco blog main
startups
boston
san francisco top stories
sanofi
alnylam pharmaceuticals
clinical trials
glaxosmithkline
vc
acetylon pharmaceuticals
alirocumab
allosteric
ambys medicines
amgen
atlas venture
atopic dermatitis
autoimmune disorders
azacitidine
beijing
beta-thalassemia
biontech
biopharmaceutical
boehringer ingelheim
brace pharma
brii bio
brii biosciences
business
cell therapy
china
cleva pharma
constellation pharmaceuticals
What
medicines
7
×
new
7
×
biotech
deal
adds
companies
company
disease
drug
formed
molecules
research
set
startup
therapeutics
vaccines
year
abbott
abbvie
acquire
address
ago
agreed
agreement
aiming
aims
alliance
allosteric
ambys
announced
approach
areas
backed
based
bets
big
billion
bio
biopharma
biosciences
Language
unset
Current search:
deals
×
medicines
×
new
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@venturebeat.com
9 years ago
Google-backed Calico and Abbott Labs spinoff will set up $1.5B research center